Genistein as a Possible Treatment for Alzheimer's Disease.

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

September 30, 2020

Study Completion Date

December 31, 2020

Conditions
Alzheimer's Disease
Interventions
DIETARY_SUPPLEMENT

Genistein

Subjects will be randomized 1:1 to receive 360 days of double blind treatment of genistein.

OTHER

Placebo

360 days of double blind treatment of placebo.

Trial Locations (2)

46010

Universitat de València, Valencia

Unknown

Hospital General Universitario, Valencia

All Listed Sponsors
collaborator

University of Valencia

OTHER

lead

Fundación para la Investigación del Hospital Clínico de Valencia

OTHER

NCT01982578 - Genistein as a Possible Treatment for Alzheimer's Disease. | Biotech Hunter | Biotech Hunter